End-zit Lotion, Augmented
NDC Package 68605-2002-2

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

End-zit (sulfur) lotions is intended for use on blemishes only. This formulation utilizes a lotion, augmented delivery system. Marketed by Abbe Laboratories, Inc., this product is identified by NDC 68605-2002 and is authorized under FDA application M006.

Identification & Billing

NDC Package Code
68605-2002-2
Package Description
17.57 g in 1 BOTTLE, GLASS
Product Code
68605-2002
11-Digit Billing Format
68605200202
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
End-zit
Non-Proprietary Name
Sulfur
Substance Name
Sulfur
Dosage Form
Lotion, Augmented - A lotion dosage form that enhances drug delivery. Augmentation does not refer to the strength of the drug in the dosage form. NOTE: CDER has decided to refrain from expanding the use of this dosage form due to difficulties in setting specific criteria that must be met to be considered "augmented".
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
SULFUR .05 g/g
Usage Information
Intended for use on blemishes only. This advanced formulation is designed to dry and aid in elimination of pimples. It is make-up quality for excellent coverage of the blemish. It is unbelievably effective, clinically tested, dermatologist approved and recommended.

Regulatory & Marketing

Labeler Name
Abbe Laboratories, Inc.
Product Type
Human Otc Drug
FDA Application #
M006
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
04-20-2004
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 68605-2002-2 identifies a specific commercial package of 17.57 g in 1 bottle, glass of End-zit, a human over the counter drug labeled by Abbe Laboratories, Inc.. This lotion, augmented is formulated for topical use and contains sulfur as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Abbe Laboratories, Inc. on April 20, 2004. The current certification is valid through December 31, 2027.

How is this Abbe Laboratories, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 68605200202. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
68605-2002-2
11-Digit CMS (5-4-2)
68605-2002-02

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.